ArticleClinical Medicine Insights. Oncology2011

Tyrosine kinase inhibitors in the treatment of advanced renal cell carcinoma: focus on pazopanib.

Naveen S Vasudev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.